Surgical Treatment of Gastroesophageal Reflux Disease and Hiatus Esophageal Hernias

Gastroesophageal reflux disease (GERD) is a chronic and recurrent condition that is linked to the retrograde passage of gastric contents, with or without duodenal contents, towards the esophagus and adjacent organs, with or without tissue damage (1).It is characterized by its chronicity and recurren...

Descripción completa

Detalles Bibliográficos
Autores: Rodríguez Temesio, Gustavo, Valsangiacomo, Pablo
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2013
País:Uruguay
Institución:Sociedad de Cirugía del Uruguay
Repositorio:Relatos de los Congresos Uruguayos de Cirugía
Idioma:español
OAI Identifier:oai:ojs2.revista.scu.org.uy:article/4831
Acceso en línea:https://revista.scu.org.uy/index.php/relatos/article/view/4831
Access Level:acceso abierto
Palabra clave:reflujo gastroesofágico
tratamiento quirúrgico
cirugía antireflujo
cirugía laparosc´opica
hernia hiatal
casos clínicos
complicaciones operatorias
Descripción
Sumario:Gastroesophageal reflux disease (GERD) is a chronic and recurrent condition that is linked to the retrograde passage of gastric contents, with or without duodenal contents, towards the esophagus and adjacent organs, with or without tissue damage (1).It is characterized by its chronicity and recurrence, as well as by being a benign pathology, but which adversely affects the quality of life of patients (2, 3, 4). The clinical presentation is highly variable, with typical symptoms being heartburn and regurgitation. Respiratory, otorhinolaryngological and chest pain are recognized as atypical symptoms betweenothers. In its evolution, it can develop complications such as esophagitis of variable degree with ulcerationand stricture, Barret's esophagus, and adenocarcinoma of the esophagus. GERD is a common disease, but with different prevalences in different countries. According to the international study DIGEST (Domestic / International Gastroentero-logy Surveillance Study) 7, 7% of the population refers symptoms of gastroesophageal reflux (5). Approximately 20% of North American adults have gastroesophageal reflux symptoms such as heartburn and acid regurgitations at least once a week (6, 7). In Uruguay, the estimated prevalence in the urban population was 4, 69, while for the populationhospital was 11.66%, using the GERD (Gastro-esophageal reflux disease Questionnaire) (8) The treatment of gastroesophageal reflux disease has undergone significant changes in the last two decades, motivated by a better study and knowledge of its aspects pathophysiological, in the use of proton pump inhibitors and in the development of laparoscopic surgery since the 1990s.